School of Pharmacy and Pharmaceutical Sciences, University of Dublin, Trinity College, Dublin 2, Ireland.
J Microencapsul. 2009 Aug;26(5):403-10. doi: 10.1080/02652040802396575.
The release of actives encapsulated in biodegradable poly-lactide-co-glycolide (PLGA)-based microparticles may be diffusion controlled, dependent on polymer degradation, or may occur by a combination of drug diffusion and polymer degradation. This report applies a model, describing combined diffusional and polymer degradation-assisted drug release, to quantify the release of fluphenazine HCl (F-HCl) from PLGA microspheres. Parameters for the release process showed that both the initial drug release phase and the polymer controlled drug release phase were dependent on the F-HCl loading of the microspheres. The percentage drug released in the burst phase and the length of the lag phase were dependent on F-HCl loading. In the degradation controlled release phase, drug release was faster the higher the loading, as shown by the decrease in t(max) from 27 to 10 days, as F-HCl loadings increased from 4.2 to 16.6%w/w. The presence of F-HCl was found to catalyse the degradation of PLGA polymer during particle manufacture and during dissolution. When compared to drug free microspheres, F-HCl accelerated PLGA degradation as shown by the approximately 5-fold increase in both PLGA degradation rate constant (k) and reduction in t(max).
包封在可生物降解的聚乳酸-共-羟基乙酸(PLGA)基微球中的活性剂的释放可能是扩散控制的,依赖于聚合物的降解,或者可能是药物扩散和聚合物降解的组合作用。本报告应用了一种描述药物扩散和聚合物降解协同作用的模型,来定量氟奋乃静 HCl(F-HCl)从 PLGA 微球中的释放。释放过程的参数表明,F-HCl 载药量既影响初始药物释放阶段,也影响聚合物控制的药物释放阶段。突释阶段的药物释放百分比和滞后阶段的长度取决于 F-HCl 的载药量。在降解控制的释放阶段,载药量越高,药物释放越快,t(max)从 27 天降至 10 天,F-HCl 的载药量从 4.2%w/w 增加到 16.6%w/w。研究发现,F-HCl 存在于颗粒制造和溶解过程中,会催化 PLGA 聚合物的降解。与不含药物的微球相比,F-HCl 加速了 PLGA 的降解,PLGA 降解速率常数(k)增加了约 5 倍,t(max)缩短。